On Monday the board of directors of US pharmaceutical company Eli Lilly and Company (NYSE:LLY) declared a dividend of USD1.50 per share of common stock for the third quarter of 2025.
This amount is unchanged from the previous quarterly dividend.
Shareholders of record at the close of business on 15 August 2025 will receive the dividend on 10 September 2025.
Lilly declares Q2 2025 dividend
Bruker acquires majority stake in RECIPE to expand clinical mass spectrometry diagnostics
Emmaus Life Sciences reports drop in revenues, increased loss in 2024
L'Oréal and WHO Foundation partner to expand global skin health access